3ml Non-Cross-Linked Ha 10mg/Ml Reyoungel Anti Choking Device Salmon Pdrn

Name: 3ml Non-Cross-Linked Ha 10mg/Ml Reyoungel Anti Choking Device Salmon Pdrn
Brand: SHANGHAI BIOHA BIOLOGICAL TECHNOLOGY COMPANY LIMITED
SKU: 2298602525

Shanghai, ChinaSHANGHAI BIOHA BIOLOGICAL TECHNOLOGY COMPANY LIMITED

US$25.00-30.00

5 Boxes

Sample price:US$25.00/box.Request sample

Product profile

Customization

Available

Product Name

Polydeoxyribonucleotide Injection

Keywords

Pdrn Injection

Model NO.

3ml

OEM & ODM Custom

Logo Custom

Main Ingredient

Polydeoxyribonucleotide (Pdrn)

Pdrn Concentration

3mg/Ml

Hyaluronic Acid Content

Non-Cross-Linked Ha 10mg/Ml

Niacinamide Content

Additional Active Ingredients

0.4% Taurine, Carnosine

Volume Per Syringe

3ml

Packaging Type

Pre-Filled Sterile Syringe

Form

Injectable Solution

Feature

Ready-to-Use, Pre-Filled and Sterile

Transport Package

Carton Packing

Specification

Standard Specifications or Customized

Trademark

Reyoungel

Origin

Shanghai, China

Production Capacity

1000000boxes/Year

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceYears of Export Experience

SHANGHAI BIOHA BIOLOGICAL TECHNOLOGY COMPANY LIMITED

Shanghai, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableAverage Response Time: ≤11.45h

AI-Powered supplier vetting

SummarySHANGHAI REYOUNGEL MEDICAL TECHNOLOGY COMPANY LIMITED is a China-based limited company in Shanghai described as both a trading company and manufacturer/factory. Its listed products are filler cannulas, meso needles, and dermal fillers. The supplier reports ISO 13485 certification, more than 10 production lines, 11–20 years of total R&D engineer experience, and sales in more than 30 countries. Export sales account for 90%, and it has self-operated import and export rights. However, the provided information does not establish current audit validity, audit performance, after-sales capability, customization services, customer references, financial credibility, raw-material traceability, or specific R&D/ODM/OEM capabilities. Several operational fields are explicitly marked unknown.

Supplier typeThe supplier is identified as a factory and, more specifically, as both a trading company and manufacturer/factory. It is a China-based limited company operating in Shanghai, indicating manufacturing involvement but also a trading function.

CertificationsThe supplier lists ISO 13485 certification, and a TUV Rheinland audit record is provided with a stated period from August 22, 2024 to August 21, 2025. However, the audit evaluation result is recorded as 0, and the provided information does not clarify the meaning of that result or establish current certification validity.

R&D capabilityThe supplier states that it uses technological breakthroughs, emphasizes technical innovation, conducts market research, listens to customer feedback, and engages in continuous product development. It also reports 11–20 years of total R&D engineer experience, but specific new-product output and SDK-related R&D capability are unknown.

Production capacityThe supplier is identified as a manufacturer/factory, lists more than 10 production lines, and offers filler cannulas, meso needles, and dermal fillers. These facts explicitly support manufacturing capacity, although the audit evaluation result of 0 is not explained in the provided information.

Client casesThe supplier states that its products are sold in more than 30 countries and recognized by customers. However, collaboration with Fortune 500 companies is unknown, and no named customers, customer projects, or verifiable case details are provided.